Wouter Verhoeven

Venture Partner

2021

Chief Executive Officer

2021

Chief Business Officer

2019 - 2021

NBE Therapeutics is a highly innovative biotech company developing next generation antibody drug conjugates. NBE was acquired by Boehringer Ingelheim in 2020.

Head of Global Business and Corporate Development, member of the Executive Committee

2014 - 2018

Head of Global Business Development, Project Management and Corporate Development, member of the Executive Committee. Responsible for all commercial activities in the company, from new business deals to sales in approved countries. Managing a team of business development specialists, commercial directors, business analyst and project managers. mAbxience is a fast growing, fully integrated biopharmaceutical company with 250+ employees specialized in research, development and manufacturing of biosimilars for the treatment and/or prevention of several diseases in diverse therapeutic areas. With headquarters in Switzerland, mAbxience is acting worldwide, creating a broad and balanced presence in all major pharmaceutical markets to address global opportunities and customers’ needs, with full-line research and manufacturing capabilities and highly qualified professionals worldwide. mAbxience is a wholly-owned subsidiary of the Insud Pharma Group, a well-established Spanish based global healthcare corporation with 6000+ employees worldwide.

Director Business Development

2013 - 2014

myTomorrows acts as an intermediary in facilitating contact between patients and their doctors and innovative bio-tech companies and government agencies. The mission of myTomorrows is to make the latest innovative drugs accessible as quickly as possible for patients who cannot afford to wait. Some patients will via their doctor have immediate access to innovative new drugs; others will have to wait a bit longer. But, ultimately, all patients will have far quicker access to effective medicines at a lower price.

Investment Manager

2011 - 2013

Investment Manager at the Dutch Greentech Fund

Director Business Development

2006 - 2011

International BD, responsible for in- and outlicensing projects, M&A and other general business development activities. Reponsible for 20+ closed deals worldwide, including in the US, Asia, Israel and multiple countries in Europe.

Business Development Associate

2003 - 2005

Responsible for general business developments tasks in the Biotechnology field. Responsibility for an outlicensing deal done in India, sold a daughter company in Argentina and supported several inlicensing and outlicensing projects in the company.

trainee

2001 - 2001

internship: preparation for ISO implementation